Skip to main content
Abpro Bio Co., Ltd. logo

Abpro Bio Co., Ltd. — Investor Relations & Filings

Ticker · 195990 ISIN · KR7195990007 KO Manufacturing
Open in API
Filings indexed 426 across all filing types
Latest filing 2026-05-20 Proxy Solicitation & In…
Country KR South Korea
Listing KO 195990

About Abpro Bio Co., Ltd.

https://abpro.co/

Abpro Bio Co., Ltd. is a company engaged in the manufacture and sale of precision machine tools. Its primary products include tapping centers, 2-spindle machining centers, and other specialized industrial machinery. In addition to its core manufacturing operations, the company has diversified its business to include a biotechnology division. This division is involved in the development of next-generation antibody therapeutics, often through exclusive development agreements and collaborations with strategic partners.

Recent filings

Filing Released Lang Actions
[기재정정]주주총회소집결의 (임시주주총회)
Proxy Solicitation & Information Statement Classification · 87% confidence The document is a detailed notice of convening an extraordinary shareholders meeting (임시주주총회), including agenda items, detailed proposals, director candidate information, and correction to a prior disclosure. It is not the full annual or interim report, nor an earnings release or dividend notice. Rather, it constitutes proxy solicitation/information statement materials provided to shareholders to inform them of the meeting and request their votes. Therefore, it fits the “Proxy Solicitation & Information Statement” category (PSI).
2026-05-20 Korean
주주총회소집공고
Proxy Solicitation & Information Statement Classification · 92% confidence The document is a formal notice of convocation of the 23rd Extraordinary Shareholders’ Meeting (“주주총회소집공고”), including the meeting date, agenda items, voting instructions (including electronic voting and proxy mechanics), plus detailed background information on outside directors’ activities/compensation, related-party transactions, and business overviews. This corresponds to proxy solicitation materials sent to shareholders to inform them and solicit votes for a shareholders’ meeting. Therefore, it is classified as a Proxy Solicitation & Information Statement.
2026-05-20 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 98% confidence The document is titled “의결권대리행사권유참고서류” (proxy solicitation reference materials) and provides detailed information about proxy solicitation for the 23rd extraordinary shareholders’ meeting, including proxy voting methods, agenda items, candidate bios, and related instructions. This clearly matches the definition of a Proxy Solicitation & Information Statement (PSI).
2026-05-20 Korean
주식병합결정
Share Issue/Capital Change Classification · 92% confidence The document is an official announcement of a share consolidation (“주식병합결정”) of ABProBio, detailing the consolidation ratio, schedule, board resolution date, and related procedural notes. This is a corporate capital structure change event (share consolidation). According to the filing definitions, this falls under Share Issue/Capital Change (Code: SHA).
2026-05-20 Korean
분기보고서 (2026.03)
Interim / Quarterly Report Classification · 95% confidence The document is titled 분기보고서 (Quarterly Report) for the 22nd fiscal period covering 2026.01.01–2026.03.31 and is a full statutory filing with detailed company overview, historical data, capital changes, financial tables and narrative. It is not a short notice or earnings release but the complete interim/quarterly report itself. Q1 2026
2026-05-15 Korean
[기재정정]주요사항보고서(전환사채권발행결정)
Capital/Financing Update Classification · 100% confidence The document is a detailed disclosure about the issuance and amendment of convertible bonds (전환사채권 발행결정) by the company AB Pro Bio. It includes specifics such as the amount of bonds issued, changes in issuance amounts, conversion terms, early redemption options, and detailed tables about bondholders and fund usage. The document is a regulatory disclosure related to capital raising through convertible bonds, not a financial report or earnings release. It is not an announcement of a report publication but a substantive update on financing activities. Therefore, it fits best under the category of Capital/Financing Update (CAP).
2026-04-30 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.